Vithal M. Kulkarni

Vascular Endothelial Growth Factor Receptor (VEGFR-2)/KDR Inhibitors: Medicinal Chemistry Perspective

Siddharth J. Modi, Vithal M. Kulkarni · Medicine in Drug Discovery · 2019 · 300 citations · Full text

Angiogenesis Inhibition, Pathology, Pharmacotherapy +20

Three-Dimensional Quantitative Structure−Activity Relationship of 1,4-Dihydropyridines As Antitubercular Agents

Prashant S. Kharkar, Bhavik Desai, Harsukh Gaveria et al. · Journal of Medicinal Chemistry · 2002 · 113 citations

Novel curcumin analogs targeting TNF-induced NF-κB activation and proliferation in human leukemic KBM-5 cells

Ajit Zambre, Vithal M. Kulkarni, Subhash Padhyé et al. · Bioorganic & Medicinal Chemistry · 2006 · 82 citations

Inflammation, Cytokine, Tnf-induced Nf-κb Activation +10

Three-Dimensional Quantitative Structure−Activity Relationship of Interleukin 1-β Converting Enzyme Inhibitors:  A Comparative Molecular Field Analysis Study

Santosh S. Kulkarni, Vithal M. Kulkarni · Journal of Medicinal Chemistry · 1999 · 60 citations

Pharmacophore generation and atom-based 3D-QSAR of novel 2-(4-methylsulfonylphenyl)pyrimidines as COX-2 inhibitors

Ujashkumar Shah, Hemantkumar Deokar, Shivajirao Kadam et al. · Molecular Diversity · 2009 · 57 citations

Combinatorial Chemistry, Engineering, Cox-2 Inhibitors +10